Shareholders meeting

Date: 27 August 2026 BSE Limited National Stock Exchange of India Limited Corporate Relation Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Bandra-Kurla Complex, Mumbai – 400001. Bandra (East), Mumbai – 400051. Scrip Code: 524404 Symbol: MARKSANS Dear Sir/Madam, Sub: Proceedings of the 34th AGM of Marksans Pharma Limited Pursuant to Regulation 30 read with Part-A of Schedule-III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, kindly find enclosed herewith proceedings of the 34th Annual General Meeting of Marksans Pharma Limited held today i.e. Thursday, 27 August 2026 at 11:00 A.M. through Video Conferencing /Other Audio Visual means deemed to be held at the registered office of the Company situated at 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400053, India. We request you to take the aforesaid on records. Thanking You. Yours faithfully, For Marksans Pharma Limited Harshavardhan Panigrahi Company Secretary Encl: As Above Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com Proceedings of the 34th Annual General Meeting of Marksans Pharma Limited held on Thursday, 27 August 2026 at 11:00 A.M. through Video Conferencing / Other Audio Visual Means (VC) Present Shareholders 1. Promoter Shareholders: 02 2. Public Shareholders: 59 Directors 1. Mr. Mark Saldanha – Chairman & Managing Director 2. Mrs. Sandra Saldanha – Whole-time Director 3. Mr. Varddhman V. Jain – Whole-time Director 4. Mr. Abhinna S. Mohanty – Independent Director and Chairman of Nomination & Remuneration Committee and Stakeholders Relationship Committee 5. Mr. Digant M. Parikh – Independent Director and Chairman of Audit Committee 6. Mrs. Shailaja Vardhan – Independent Director 7. Mr. Srinivas Mishra – Independent Director In Attendance 1. Mr. Jitendra Sharma – Chief Financial Officer 2. Mr. Harshavardhan Panigrahi – Company Secretary 3. Mr. Harsh Vajani – Statutory Auditor 4. Mr. Jinesh Dedhia – Secretarial Auditor & Scrutinizer 1. Date, Time and Venue of the Meeting: The AGM of the Members of the Company was held on Thursday, 27 August 2026 at 11:00 a.m. through Video Conferencing / Other Audio Visual means (VC). For the purpose of recording the proceedings, the AGM was deemed to have been held at the registered office of the Company at 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400053, India. 2. Brief details of the items deliberated at the meeting: a. Mr. Mark Saldanha, Chairman chaired the proceedings of the meeting. b. Mr. Harshavardhan Panigrahi, Company Secretary, explained the procedure for conducting the meeting through VC as well as voting during the AGM. c. The Chairman informed that, all the Directors of the Company, except Dr. Sunny Sharma who could not attend the AGM due to his pre-occupations, and Mr. Jitendra Sharma - Chief Financial Officer attended the AGM from their respective locations. The Chairman further informed that Mr. Digant Mahesh Parikh - Chairman of the Audit Committee and Mr. Abhinna Sundar Mohanty - Chairman of the Stakeholders Relationship Committee and the Nomination and Remuneration Committee attended the AGM from their respective locations. The Chairman further informed that representative of Statutory Auditor, Secretarial Auditor and Scrutinizer also attended the meeting from their respective locations. Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com d. The requisite quorum being present, the Chairman called the meeting in order. e. The Chairman informed that the meeting was being held through VC in accordance with the provisions of Companies Act, 2013, circulars issued by the Ministry of Corporate Affairs and SEBI. f. With the consent of the members, the Notice convening the 34th AGM and the Auditor's Reports were taken as read. g. The Chairman then delivered his speech. h. The Company Secretary informed the members that the Board of the Company had appointed Mr. Jinesh Dedhia, Practicing Company Secretary, to act as the Scrutinizer for the remote e-voting process and for its completion in a fair and transparent manner and to provide a consolidated report thereof. i. The Company Secretary further informed that members who did not vote earlier through remote e-voting might vote electronically during the course of the meeting. j. The Company Secretary then called the names of those members who had registered themselves to speak or ask questions pertaining to the performance of the Company during the Financial Year 2025-26, one by one. k. The members during their speech expressed satisfaction on the performance of the Company and complimented the Board of Directors and management for the same. They also gave some suggestions and raised few queries. l. Clarifications were provided by the Chairman to the queries raised by the members at the meeting. m. The Company Secretary then informed that e-voting process would remain open for next 15 minutes. n. The Company Secretary further informed that results of voting would be announced by 28 August 2026 after receipt of consolidated voting reports from the Scrutinizer by intimation to the Stock Exchanges and would also be placed on the website of the Company www.marksanspharma.com. o. The Chairman then thanked all the members of the Company for their continued trust and confidence in the Company. He also thanked all the Board members for their continued guidance and the entire Marksans management team for their sincere efforts and contribution. p. The Chairman declared that the meeting shall stand concluded post 15 minutes from then. q. The following items of Ordinary and Special businesses as per the Notice of AGM dated 03 July 2026 were transacted through remote e-voting and through e-voting during the AGM: - Ordinary Business Marksans Pharma Ltd. 11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai - 400 053 Tel.: +91 22 4001 2000 E-mail: companysecretary@marksanspharma.com www.marksanspharma.com 1. To receive, consider and adopt: a) the Audited Standalone Financial Statements of the Company for the Financial Year ended 31 March 2026, comprising of Standalone Balance Sheet as at 31 March 2026, Standalone Statement of Profit & Loss and Standalone Cash Flow Statement for the Financial Year 01 April 2025 to 31 March 2026 including its Schedules and the Notes attached thereto and forming part thereof along with the reports of the Board of Directors and the Statutory Auditors thereon; and b) the Audited Consolidated Financial Statements of the Company for the Financial Year ended 31 March 2026, comprising of Consolidated Balance Sheet as at 31 March 2026, Consolidated Statement of Profit & Loss and Consolidated Cash Flow Statement for the Financial Year 01 April 2025 to 31 March 2026 including its Schedules and the Notes attached thereto and forming part thereof along with the reports of the Statutory Auditors thereon. 2. To declare dividend on equity shares recommended by the Board of Directors at its meeting held on 26 May 2026. The Board of Directors had recommended equity dividend of Rs. 0.90 (90%) per equity share of Re. 1/- each face value. 3. To appoint a director in place of Dr. Sunny Sharma (DIN: 02267273) who retires by rotation and being eligible offered herself for re-appointment. Special Business 4. To approve re-appointment of and remuneration payable to Mrs. Sandra Saldanha (DIN: 00021023) as the Whole-time Director of the Company for a further period of three (3) years with effect from 25 September 2026. 3. Manner of approval: • Pursu [Showing first 8,000 characters — download PDF for full document]